Get started
Eocene Ltd. logo

EOCN

NASDAQ

Eocene Ltd.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2014
Follow + get alerts
Website

Eocene Ltd. (EOCN) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for EOCN in the last 30 days.

EoCene Ltd. (NASDAQ: EOCN) is a GI-focused medtech and biopharmaceutical company headquartered in Ramat Gan, Israel, dedicated to advancing innovative solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. The Company is building a diversified platform that combines medical devices, therapeutics and enabling technologies to address significant unmet clinical needs and improve patient outcomes. EoCene's wholly owned subsidiary, Colospan Ltd., is a commercial-stage medical device company developing solutions designed to transform postoperative colorectal care. Its flagship product, CG-100, is an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas, offering a less invasive alternative to current surgical practice.

Financial highlights

Full financials
Net income, FY2025
-$10.31M
Cash
$3.98M

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

Latest news

0 items

No recent news.

EOCN FAQ

8 questions
  • What does Eocene Ltd. do?
    EoCene Ltd. (NASDAQ: EOCN) is a GI-focused medtech and biopharmaceutical company headquartered in Ramat Gan, Israel, dedicated to advancing innovative solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. The Company is building a diversified platform that combines medical devices, therapeutics and enabling technologies to address significant unmet clinical needs and improve patient outcomes. EoCene's wholly owned subsidiary, Colospan Ltd., is a commercial-stage medical device company developing solutions designed to transform postoperative...
  • Is EOCN profitable?
    No. Eocene Ltd. reported a net loss of $10.31M for fiscal 2025 (ended Dec 31, 2025).
  • How much cash and debt does EOCN have?
    Eocene Ltd. reported $3.98M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does EOCN stock trade?
    Eocene Ltd. (EOCN) is listed on NASDAQ.
  • What sector and industry is EOCN in?
    Eocene Ltd. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Eocene Ltd. go public?
    Eocene Ltd. (EOCN) completed its IPO in 2014.
  • What companies are similar to EOCN?
    Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare EOCN side-by-side with any of them on Quantisnow.
  • How can I track EOCN on Quantisnow?
    Quantisnow aggregates Eocene Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EOCN to receive live email and push alerts on every new disclosure.